TJ-100 Pharmacokinetic study

Pharmacokinetic study of single oral administration of Daikenchuto (DKT: TJ-100) in healthy volunteers

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1080221080

Enrollment

Registered

2010-04-27

Start date

2010-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

investigational material(s) Generic name etc : TJ-100 [Tsumura Daikenchuto Extract Granules for prescription] INN of investigational material : Therapeutic category code : 52- Chinese medicines Dosag

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Subject body mass index (BMI) is between 18.5 and 25 kg/m2 2)Willing and able to provide written, signed informed consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics and safety assessment	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026